Table of contents:
Flatiron Health Overview
Flatiron Health, a Roche company, is a health technology and services company dedicated to improving cancer care. Founded in 2012, Flatiron Health’s mission is to deliver the power of real-world evidence and technology to make cancer care more personalized, effective, and accessible.
Flatiron Health has played a pivotal role in advancing oncology research and care. The company’s OncoCloud platform, a cloud-based electronic health record (EHR) system specifically designed for oncology, has been adopted by over 280 cancer centers and hospitals across the United States.
Data and Analytics
Flatiron Health’s data and analytics capabilities are a cornerstone of its offerings. The company has collected and curated a vast database of real-world cancer data, representing over 2.5 million patients and 20 billion data points. This data enables Flatiron Health to generate insights into cancer patterns, treatment outcomes, and patient experiences.
Clinical Trials and Research
Flatiron Health’s data and technology also support clinical trials and research. The company collaborates with leading cancer centers and pharmaceutical companies to design and conduct clinical trials, leveraging its real-world data to identify eligible patients and monitor outcomes.
Patient Care and Support
Flatiron Health is committed to improving patient care and support. The company’s patient portal, MyJourney, provides patients with access to their medical records, treatment plans, and support resources. Flatiron Health also offers a range of patient support services, including personalized care navigation, financial assistance, and emotional support.
Flatiron Health’s Data and Technology
Flatiron Health possesses unparalleled capabilities in data collection and analysis, with a particular focus on real-world oncology data. This data, derived from electronic health records (EHRs) and other sources, provides a comprehensive view of cancer care, including treatment patterns, outcomes, and patient-reported experiences.
Flatiron Health leverages cutting-edge technology, including machine learning and artificial intelligence (AI), to extract meaningful insights from its vast data repository. These insights empower researchers, clinicians, and drug developers to improve cancer care in several ways:
Data-Driven Research
- Flatiron Health’s data enables researchers to conduct large-scale studies on cancer incidence, prevalence, and outcomes, providing valuable insights into cancer trends and patterns.
- The company’s data also supports the development of predictive models that can identify patients at high risk of developing cancer or experiencing adverse events, enabling personalized and proactive care.
Clinical Decision Support
- Flatiron Health’s technology provides real-time clinical decision support tools that assist clinicians in making informed treatment decisions. These tools leverage machine learning algorithms to analyze patient data and identify potential risks or opportunities for optimizing care.
- For example, Flatiron Health’s OncoEMR platform integrates with EHRs to provide clinicians with personalized treatment recommendations based on the latest clinical evidence and real-world data.
Drug Development
- Flatiron Health’s data and technology play a crucial role in drug development by providing insights into the safety and efficacy of new cancer therapies.
- The company’s data can be used to design clinical trials, identify potential patient populations for new drugs, and monitor the long-term outcomes of patients treated with experimental therapies.
Flatiron Health’s Products and Services
Flatiron Health offers a range of products and services designed to enhance cancer research, clinical trials, and patient care. The company’s flagship product, the OncologyCloud platform, is a comprehensive suite of tools that empowers healthcare providers with real-world data and analytics to improve patient outcomes.
OncologyCloud Platform
OncologyCloud is a cloud-based platform that integrates data from electronic health records, claims, and molecular profiling. This data is then analyzed using advanced algorithms to generate insights that can help clinicians make more informed decisions about cancer care.
- Real-World Data: OncologyCloud provides access to a vast repository of real-world data, including patient demographics, medical history, treatment plans, and outcomes. This data is essential for understanding the effectiveness of different cancer treatments and identifying trends in cancer care.
- Analytics: OncologyCloud’s analytics tools allow clinicians to analyze data in a variety of ways, including:
- Cohort identification: Clinicians can use OncologyCloud to identify patients who meet specific criteria, such as those with a particular type of cancer or who have received a particular treatment.
- Treatment effectiveness: OncologyCloud can be used to compare the effectiveness of different cancer treatments, both in terms of survival rates and quality of life.
- Risk prediction: OncologyCloud can be used to predict the risk of developing cancer or the likelihood of a patient’s cancer recurring.
- Clinical Decision Support: OncologyCloud provides clinicians with real-time clinical decision support tools that can help them make more informed decisions about patient care. These tools include:
- Treatment guidelines: OncologyCloud provides access to the latest cancer treatment guidelines, which can help clinicians stay up-to-date on the best practices for cancer care.
- Expert consultations: OncologyCloud allows clinicians to consult with experts in cancer care, who can provide guidance on complex cases.
Support for Cancer Research and Clinical Trials
Flatiron Health’s products and services also play a vital role in cancer research and clinical trials. The company’s data and analytics platform can be used to:
- Identify potential trial participants: OncologyCloud can be used to identify patients who meet the eligibility criteria for clinical trials, which can help accelerate the recruitment process.
- Monitor patient outcomes: OncologyCloud can be used to monitor patient outcomes during clinical trials, which can help researchers assess the safety and effectiveness of new treatments.
- Generate real-world evidence: OncologyCloud can be used to generate real-world evidence on the effectiveness of new cancer treatments, which can help inform clinical practice and regulatory decisions.
Flatiron Health’s Impact on Cancer Care
Flatiron Health’s data and technology have revolutionized cancer research and treatment. By collecting and analyzing vast amounts of real-world data from cancer patients, Flatiron Health has gained unprecedented insights into the disease. This information has led to the development of new treatments, improved patient outcomes, and accelerated drug development.
Improved Patient Outcomes
Flatiron Health’s data has helped to identify factors that contribute to better patient outcomes. For example, the company’s research has shown that patients who receive care at specialized cancer centers have better survival rates than those who receive care at community hospitals. This information has led to the development of new guidelines for cancer care, which have helped to improve patient outcomes.
Accelerated Drug Development
Flatiron Health’s data has also been used to accelerate the development of new cancer drugs. By providing researchers with real-world data on how patients respond to different treatments, Flatiron Health has helped to identify promising new drugs and shorten the time it takes to bring them to market. This has led to the development of new treatments that have saved the lives of countless cancer patients.
Flatiron Health’s Partnerships and Collaborations
Flatiron Health has established strategic partnerships with various organizations in the healthcare industry, including pharmaceutical companies, academic institutions, and healthcare providers. These collaborations aim to leverage Flatiron Health’s data and technology capabilities to advance cancer research and improve patient care.
One of the key areas of collaboration is with pharmaceutical companies. Flatiron Health provides real-world data and analytics to support drug development and clinical trials. This data helps pharmaceutical companies design more effective treatments and evaluate the safety and efficacy of their products in real-world settings.
Partnerships with Academic Institutions
Flatiron Health also collaborates with academic institutions to conduct research and develop new cancer treatments. These partnerships provide access to Flatiron Health’s data and technology, enabling researchers to conduct large-scale studies and gain insights into cancer biology and treatment outcomes.
Collaborations with Healthcare Providers
Flatiron Health collaborates with healthcare providers to integrate its technology and data into clinical workflows. This integration enables providers to access real-time data on their patients, including treatment history, outcomes, and molecular profiling. This information supports personalized treatment decisions and improves the quality of care for cancer patients.
Flatiron Health’s Culture and Values
Flatiron Health fosters a culture of innovation, collaboration, and patient-centricity. The company believes that these values are essential to driving progress in cancer care.
Flatiron Health’s employees are passionate about making a difference in the lives of cancer patients. They are committed to developing products and services that improve patient outcomes and reduce the burden of cancer.
Innovation
Flatiron Health is constantly innovating new ways to improve cancer care. The company’s data science team is developing new algorithms to identify patterns in cancer data. These algorithms can be used to develop new treatments, predict patient outcomes, and improve patient care.
Collaboration
Flatiron Health collaborates with a wide range of partners, including hospitals, cancer centers, and pharmaceutical companies. These partnerships allow Flatiron Health to share its data and expertise with others in the cancer care community.
Patient-centricity
Flatiron Health puts patients at the center of everything it does. The company’s products and services are designed to improve the patient experience and make it easier for patients to access the care they need.
Flatiron Health’s culture and values shape its products, services, and employee experience. The company’s commitment to innovation, collaboration, and patient-centricity has helped it become a leader in cancer care.
Flatiron Health’s Future Outlook
Flatiron Health is poised for continued growth and expansion in the years to come. The company has ambitious plans to develop new products and services that will help to improve the lives of cancer patients. Flatiron Health is also well-positioned to take advantage of emerging technologies and healthcare trends that will shape the future of cancer care.
New Product Development
Flatiron Health is committed to developing new products and services that will help to improve the lives of cancer patients. The company is currently working on a number of new products, including:
- A new platform for sharing and analyzing cancer data
- A new tool for predicting the risk of cancer recurrence
- A new app for helping cancer patients manage their care
These new products and services will help to improve the lives of cancer patients by providing them with more information, better tools, and more support.
Market Opportunities
Flatiron Health is also well-positioned to take advantage of emerging market opportunities. The company is currently expanding its operations into new markets, including:
- Europe
- Asia
- Latin America
These new markets represent a significant growth opportunity for Flatiron Health. The company is well-positioned to take advantage of these opportunities by providing its products and services to a wider range of cancer patients.
Emerging Technologies and Healthcare Trends
Flatiron Health is also closely monitoring emerging technologies and healthcare trends that could impact the future of cancer care. These trends include:
- The increasing use of artificial intelligence (AI)
- The development of new cancer treatments
- The shift towards value-based care
Flatiron Health is well-positioned to take advantage of these trends by developing new products and services that meet the changing needs of cancer patients and healthcare providers.
